Abstract:Animals posses a large variety of antimicrobial peptides (AMPs) that serve as effective components in innate host defenses against microbial infections. These antimicrobial peptides differ in amino acid composition, range of antimicrobial specificities, hemolysis, cytotoxicity and mechanisms of action. This study was designed to evaluate their therapeutic potential of the following six antimicrobial peptides initially found from animals: cecropin P1, indolicidin, LL-37, palustrin-OG1, LFP-20 and LFB-11. Our results indicated that cecropin P1 possessed the most desired biological activity, with fast and potent antimicrobial activity but only slight hemolytic or cytotoxic activity against human cells. Indolicidin was more effective against gram-positive bacteria but with higher hemolytic and cytotoxic activity on human peripheral blood mononuclear cell (PBMCs) ( P < 0.05). Although LFP-20 and LFB-11 had moderate activity against tested strains and need 30 min to kill E . coli , they showed almost no hemolytic and cytotoxic activity towards PBMCs ( P < 0.01). Indolicidin could form pores of well-defined structure in bacterial membranes whereas lysis of E . coli cells was observed after addition LFB-11 and LL-37 at 1 × MIC for 1 h. LL-37 treatment could lead to the leakage of entire bacterial cytoplasmic contents. The most obvious phenomenon was protuberant structures on the E . coli cell surface after incubation with LFP-20, cecropin P1 and palustrin-OG1. The results presented here illustrate that AMPs derived from different animals exhibited different antimicrobial characteristics. Because of their potent and broad-spectrum antimicrobial activity, low cytotoxicity towards normal cells, and the unique mechanism of action, these peptides may provide the impetus for the development of novel strategies for the prevention of bacterial infections in animals.

PROGRESS ON ANTIPROTOZOA ACTIVITY OF ANTIMICROBIAL PEPTIDES

Advances on Mechanism,bioactivity and Application of Antimicrobial Peptides

Therapeutic potential of antimicrobial peptides against pathogenic protozoa

Bioactivity, Action Mechanism and Application of Antimicrobial Peptides

Advances in microbial antimicrobial peptides expression system and transformation strategy

Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides

Review on Research Progresses and Prospects in Biological Control of Antimicrobial Peptides

Bioactive Antimicrobial Peptides: A New Weapon to Counteract Zoonosis

Marine Invertebrate Peptides: Antimicrobial Peptides

Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields

Antimicrobial peptides: mechanism of action, activity and clinical potential

Advanc in Antimicrobial Peptides

Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era

Advance in the Research of Antimicrobial Peptide Protegrins

Advancements, challenges and future perspectives on peptide-based drugs: Focus on antimicrobial peptides

Antimicrobial Peptides: Design, Chemical Synthesis, Activity Evaluation, and Application

Immunomodulatory function and action mechanism of antimicrobial peptides

Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

Antimicrobial peptides derived from different animals: comparative studies of antimicrobial properties, cytotoxicity and mechanism of action

Improving the Activity of Antimicrobial Peptides Against Aquatic Pathogen Bacteria by Amino Acid Substitutions and Changing the Ratio of Hydrophobic Residues